The prognostic significance of perineural invasion and race in men considering active surveillance

BJU International

Volumn 114, Issue 1, 2014, Pages 75-80

  Cohn, Joshua A ^a   Dangle, Pankaj P ^a   Wang, Chihsiung E ^b   Brendler, Charles B ^b   Novakovic, Kristian R ^b   McGuire, Michael S ^b   Helfand, Brian T ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

biopsy; pathology; prostatic neoplasms

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CAUCASIAN; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PATIENT COUNSELING; PATIENT SELECTION; PERINEURAL INVASION; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RACE DIFFERENCE; RISK ASSESSMENT; TUMOR VOLUME;

BIOPSY; PATHOLOGY; PROSTATIC NEOPLASMS;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; WATCHFUL WAITING;

EID: 84903379071     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12463     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts and Figures 2013 [Internet]. Atlanta, GA: American Cancer Society, 2013: Available at: http://www.cancer.org/ research/cancerfactsstatistics/cancerfactsfigures2013/index. Accessed October 2013
2. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1995; 274: 1445-1449
3. Etzioni R, Gulati R, Falcon S, Penson DF,. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Med Decis Making 2008; 28: 323-331
4. Bouchardy C, Fioretta G, Rapiti E, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer 2008; 123: 421-429
5. Catalona WJ, Smith DS, Ratliff TL, Basler JW,. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270: 948-954
6. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR,. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 2007; 178: S14-19
7. Welch HG, Albertsen PC,. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325-1329
8. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95: 868-878
9. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126-131
10. Dall'Era MA, Konety BR, Cowan JE, et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008; 112: 2664-2670
11. Van den Bergh RC, Roemeling S, Roobol MJ, et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009; 55: 1-8
12. DeLancey JO, Wood DP Jr, He C, et al. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology 2013; 81: 354-357
13. Harnden P, Shelley MD, Clements H, et al. The prognostic significance of perineural invasion in prostatic cancer biopsies. Cancer 2007; 109: 13-24
14. Feng FY, Qian Y, Stenmark MH, et al. Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy. Int J Radiat Oncol Biol Phys 2011; 81: e361-367
15. Cozzi G, Rocco BM, Grasso A, et al. Perineural invasion as a predictor of extraprostatic extension of prostate cancer: a systematic review and meta-analysis. Scand J Urol 2013; doi: 10.3109/21681805.2013.776106 [Epub ahead of print]
16. Elharram M, Margel D, Finelli A, et al. Perineural invasion on prostate biopsy does not predict adverse pathological outcome. Can J Urol 2012; 19: 6567-6572
17. Loeb S, Epstein JI, Humphreys EB, Walsh PC,. Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes? BJU Int 2010; 105: 1510-1513
18. O'Malley KJ, Pound CR, Walsh PC, Epstein JI, Partin AW,. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology 2002; 59: 85-90
19. Ding W, Lee J, Chamberlain D, Cunningham J, Yang L, Tay J,. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy. Int J Radiat Oncol Biol Phys 2012; 84: 962-967
20. Hassan MO, Maksem J,. The prostatic perineural space and its relation to tumor spread: an ultrastructural study. Am J Surg Pathol 1980; 4: 143-148
21. Ayala GE, Dai H, Ittmann M, et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 2004; 64: 6082-6090
22. Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD,. Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active Surveillance. J Urol 2008; 180: 1964-1968
23. Porten SP, Whitson JM, Cowan JE, et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011; 29: 2795-2800
24. Motamedinia P, RiChard JL, McKiernan JM, DeCastro GJ, Benson MC,. Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance. Urology 2012; 80: 1070-1074
25. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y,. Investigating Black-White differences in prostate cancer prognosis: a systematic review and meta-analysis. Int J Cancer 2008; 123: 430-435
26. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB,. Survival of blacks and whites after a cancer diagnosis. JAMA 2002; 287: 2106-2113
27. Merrill RM, Lyon JL,. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 2000; 55: 730-735
28. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B,. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 1995; 274: 1599-1605
29. Freedland SJ, Sun L, Kane CJ, et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008; 102: 969-974